Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

[1]  G. Heiss,et al.  Dietary antioxidants and carotid artery wall thickness. The ARIC Study. Atherosclerosis Risk in Communities Study. , 1995, Circulation.

[2]  P. Dowd,et al.  On the mechanism of the anticlotting action of vitamin E quinone. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Steinberg.  Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? , 1995, The Lancet.

[4]  S. Azen,et al.  Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. , 1995, JAMA.

[5]  C. van der Veen,et al.  Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. , 1995, Biochimica et biophysica acta.

[6]  J. Skepper,et al.  Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. , 1995, Atherosclerosis.

[7]  D. Leake,et al.  Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. , 1994, The Biochemical journal.

[8]  J. Tuomilehto,et al.  Diagnosis of acute myocardial infarction by MONICA and FINMONICA diagnostic criteria in comparison with hospital discharge diagnosis. , 1994, Journal of clinical epidemiology.

[9]  Mitchinson Mj.  The new face of atherosclerosis. , 1994 .

[10]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[11]  U. Keil,et al.  Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels. , 1993, Atherosclerosis.

[12]  J. Manson,et al.  Vitamin E consumption and the risk of coronary disease in women. , 1993, The New England journal of medicine.

[13]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[14]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[15]  D. Steinberg,et al.  Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland. , 1992, Circulation.

[16]  T. Lüscher,et al.  Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. , 1992, Circulation research.

[17]  C. Teng,et al.  Effect of tocopherol on platelet aggregation in non-insulin-dependent diabetes mellitus: ex vivo and in vitro studies. , 1992, Journal of the Formosan Medical Association = Taiwan yi zhi.

[18]  M. Steiner.  Influence of vitamin E on platelet function in humans. , 1991, Journal of the American College of Nutrition.

[19]  D. Wood,et al.  Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene , 1991, The Lancet.

[20]  F. Kelly,et al.  Time course of vitamin E repletion in the premature infant , 1990, British Journal of Nutrition.

[21]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[22]  A. Hofman,et al.  Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. , 1987, The American journal of clinical nutrition.

[23]  J. Salonen,et al.  Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. , 1985, The American journal of cardiology.

[24]  J L Witztum,et al.  Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. J. Mitchinson,et al.  Macrophages, oxidised lipids and atherosclerosis. , 1983, Medical hypotheses.

[26]  E. Falk.  Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. , 1983, British heart journal.

[27]  M. J. Mitchinson,et al.  Insoluble lipids in human atherosclerotic plaques. , 1982, Atherosclerosis.

[28]  M. Davies,et al.  The pathological basis and microanatomy of occlusive thrombus formation in human coronary arteries. , 1981, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[29]  R. Watson,et al.  On the spread of a disease with gamma distributed latent and infectious periods , 1980 .

[30]  S. Pocock.  Group sequential methods in the design and analysis of clinical trials , 1977 .

[31]  M. Horwitt,et al.  RELATIONSHIP BETWEEN TOCOPHEROL AND SERUM LIPID LEVELS FOR DETERMINATION OF NUTRITIONAL ADEQUACY * , 1972, Annals of the New York Academy of Sciences.